Electromed (ELMD) CFO Bradley Nagel Exercises Options, Sells Shares

What Happened Bradley M. Nagel, Chief Financial Officer of Electromed, exercised stock options to acquire 9,601 shares (4,334 @ $10.25 and 5,267 @ $10.71) for a total exercise cost of $100,834, and sold a total of 11,801 shares in open-market transactions on June 4, 2026 for combined gross proceeds of approximately $428,937 (11,620 shares at a weighted average ~$36.34 and 181 shares at a weighted average ~$37.11). The filing also reports the derivative-conversion lines associated with the option exercises (reported as $0 on two derivative disposal lines).

Key Details

• Transaction date: June 4, 2026 (Form 4 filed June 8, 2026).
• Option exercises: 4,334 shares @ $10.25 = $44,424; 5,267 shares @ $10.71 = $56,410 (total paid ≈ $100,834).
• Open-market sales: 11,620 shares (weighted avg ≈ $36.34) = $422,219 (see F1); 181 shares (weighted avg ≈ $37.11) = $6,718 (see F2). Total sales ≈ $428,937.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnotes: F1/F2 explain the weighted-average sale prices and that multiple sale prices occurred (the filer will provide per-price breakdown on request). F3 notes remaining option shares are scheduled to vest/become exercisable on June 30, 2026.
• Timeliness: Form filed June 8 covering June 4 transactions; the excerpt does not indicate a late-filing flag.

Context

• This was an option exercise followed by open-market sales. That pattern (exercise then immediate sale) is commonly used to cover exercise costs, taxes, or to realize gains — the filing shows both the exercise payments and the subsequent sales but does not state the filer’s motive.
• Sales by executives are common for liquidity or tax reasons and are not, by themselves, a definitive signal about company prospects.